Eli Lilly and Company (LLY) Announces the Launch of its Employer Connect Platform

Eli Lilly and Company (NYSE:LLY) is one of the best stocks that will always grow.

Eli Lilly and Company (NYSE:LLY) announced on March 5 the launch of its Employer Connect platform, introducing new options to help in closing the access gap in U.S. obesity care. The platform expands choice, allowing coordination between employers and independent program administrators for the development of flexible and transparent solutions that support employee access to obesity management medicines.

Ilya Yuffa, executive vice president and president, Lilly USA and Global Customer Capabilities, stated that in today’s world, starting or staying on treatment for a number of people living with obesity is not just a medical decision, but rather an “access decision driven by coverage and cost”. To deal with such challenges, Eli Lilly and Company (NYSE:LLY) is building “an employer program that connects employers to a range of independent program administrators and cost-sharing solutions” to ease access to prescribed treatment at reduced out-of-pocket costs for their employees. These programs range from those focused on benefits administration to those offering holistic obesity management.

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies.

While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Follow Insider Monkey on Google News.